Stella Vnook
CEO,
Likarda Inc.
United States
Dr. Stella Vnook is a distinguished pharmaceutical executive, serial entrepreneur, highly respected CEO and founder of multiple biotech companies and visionary leader with a proven track record of success in the biotechnology and life sciences industries. With over 25 years of experience, Dr. Vnook has played a pivotal role in shaping the future of companies, such as Merck and Co, Jazz Pharmaceuticals and Catalent, and small start-ups through her leadership, innovation, and commitment to advancing medical science.
Dr. Vnook's journey in the biotech industry began with her groundbreaking research in molecular biology and drug discovery research at Temple School of Medicine Emergency Medicine. Vnook earning her a Doctorate in Public Health/ Healthcare Economics, as well as Degree in Pharmacy specializing in Pharmacology and Oncology, Master of Business Administration focusing in Global Marketing in addition to her portfolio of degrees in Biology, Anthropology and Mathematics. Her passion for translating scientific innovation into tangible therapeutic solutions led her to found her first biotech startup, MaiCell and later NAKI Therapeutics and Diverse Biotech BioSciences.
As Likarda's CEO, Vnook leverages her expertise to drive innovation, expanding the company’s impact in cell therapy and regenerative medicine.
Sessions
-
10-Feb-2025